ABMT (Advanced BioMedical Technologies) Total Operating Expense: $0.51 Mil (TTM As of Jul. 2021)


What is Advanced BioMedical Technologies Total Operating Expense?

Advanced BioMedical Technologies ABMT Total Operating Expense is $0.51 Mil as of Jul. 2021.

Advanced BioMedical Technologies's Total Operating Expense for the three months ended in Jul. 2021 was $0.11 Mil. Advanced BioMedical Technologies's Total Operating Expense for the trailing twelve months (TTM) ended in Jul. 2021 was $0.51 Mil.

Advanced BioMedical Technologies Total Operating Expense Related Terms

Advanced BioMedical Technologies Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Total Operating Expense Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.40 0.63 0.61 0.39

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.15 0.13 0.11 0.11

Advanced BioMedical Technologies Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jul. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.51 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Total Operating Expense of $0.51 Mil as of Jul. 2021. Total operating expense is the primary recurring expense associated with central operations. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Total Operating Expense too high?
Advanced BioMedical Technologies' current Total Operating Expense is $0.51 Mil.
How does Advanced BioMedical Technologies' Total Operating Expense compare to VYCO and ADMT?
Advanced BioMedical Technologies' Total Operating Expense of $0.51 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Total Operating Expense is $0.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Total Operating Expense of $0.51 Mil. The current Total Operating Expense is $0.51 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Total Operating Expense is $0.51 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.